Lumisys has bolstered its position in the x-ray film digitizermarket by acquiring X-Ray Scanner Corp. The deal was completedMarch 13 and Lumisys has begun integrating XRS into its company,according to John Burgess, vice president of sales and
Lumisys has bolstered its position in the x-ray film digitizermarket by acquiring X-Ray Scanner Corp. The deal was completedMarch 13 and Lumisys has begun integrating XRS into its company,according to John Burgess, vice president of sales and marketingfor Lumisys, of Sunnyvale, CA.
Lumisys is the only player in the high-end laser film digitizermarket in the U.S., but for several years has wanted to add lowerpriced CCD-based digitizers to its product line. A proposed mergerin 1993 with CCD digitizer manufacturer Vision Ten fell throughdue to litigation Vision Ten was involved in (SCAN 4/7/93 and1/27/93).
XRS has six CCD digitizer products and a 20% share of the CCDdigitizer market. Lumisys will move the Torrance, CA, office ofXRS to Sunnyvale this summer, Burgess said. The office has about12 employees and produced annual sales of about $1 million. Annualsales of Lumisys are about $12 million, according to Burgess.
Lumisys believed it needed to broaden its digitizer line tocover lower price points and preferred to do so through acquisitionrather than developing new products in-house, Burgess said.
"There was a real opportunity to expand our product lineand take advantage of some of the developments they've made,"Burgess told SCAN. "We will now cover the entire range ofscanner capabilities and prices."
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.